Simons M - Search Results

1

Medical device development: from prototype to regulatory approval.

Kaplan AV, Baim DS, Smith JJ, Feigal DA, Simons M, Jefferys D, Fogarty TJ, Kuntz RE, Leon MB. Kaplan AV, et al. Among authors: simons m. Circulation. 2004 Jun 29;109(25):3068-72. doi: 10.1161/01.CIR.0000134695.65733.64. Circulation. 2004. PMID: 15226221 Review. No abstract available.

2

Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy.

Leclerc G, Isner JM, Kearney M, Simons M, Safian RD, Baim DS, Weir L. Leclerc G, et al. Among authors: simons m. Circulation. 1992 Feb;85(2):543-53. doi: 10.1161/01.cir.85.2.543. Circulation. 1992. PMID: 1735150

3

Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

Laham RJ, Cohen DJ, Kuntz RE, Baim DS, Lorell BH, Simons M. Laham RJ, et al. Among authors: simons m. Heart. 1996 Jan;75(1):67-71. doi: 10.1136/hrt.75.1.67. Heart. 1996. PMID: 8624876 Free PMC article.

4

Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization.

Laham RJ, Simons M, Pearlman JD, Ho KK, Baim DS. Laham RJ, et al. Among authors: simons m. J Am Coll Cardiol. 2002 Jan 2;39(1):1-8. doi: 10.1016/s0735-1097(01)01691-6. J Am Coll Cardiol. 2002. PMID: 11755279 Free article. Clinical Trial.

5

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.

Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, Chronos NA. Simons M, et al. Circulation. 2002 Feb 19;105(7):788-93. doi: 10.1161/hc0802.104407. Circulation. 2002. PMID: 11854116 Clinical Trial.

6

The effect of intracoronary fibroblast growth factor-2 on restenosis after primary angioplasty or stent placement in a pig model of atherosclerosis.

Post MJ, Laham RJ, Kuntz RE, Novicki D, Simons M. Post MJ, et al. Among authors: simons m. Clin Cardiol. 2002 Jun;25(6):271-8. doi: 10.1002/clc.4960250606. Clin Cardiol. 2002. PMID: 12058790 Free PMC article.

7

Post-market approval surveillance: a call for a more integrated and comprehensive approach.

Mehran R, Leon MB, Feigal DA, Jefferys D, Simons M, Chronos N, Fogarty TJ, Kuntz RE, Baim DS, Kaplan AV. Mehran R, et al. Among authors: simons m. Circulation. 2004 Jun 29;109(25):3073-7. doi: 10.1161/01.CIR.0000134694.78653.B6. Circulation. 2004. PMID: 15226222 Review. No abstract available.

8

Syndecans: new kids on the signaling block.

Tkachenko E, Rhodes JM, Simons M. Tkachenko E, et al. Among authors: simons m. Circ Res. 2005 Mar 18;96(5):488-500. doi: 10.1161/01.RES.0000159708.71142.c8. Circ Res. 2005. PMID: 15774861 Review.

9

Angiogenesis: where do we stand now?

Simons M. Simons M. Circulation. 2005 Mar 29;111(12):1556-66. doi: 10.1161/01.CIR.0000159345.00591.8F. Circulation. 2005. PMID: 15795364 Review. No abstract available.

10

PKCalpha activates eNOS and increases arterial blood flow in vivo.

Partovian C, Zhuang Z, Moodie K, Lin M, Ouchi N, Sessa WC, Walsh K, Simons M. Partovian C, et al. Among authors: simons m. Circ Res. 2005 Sep 2;97(5):482-7. doi: 10.1161/01.RES.0000179775.04114.45. Epub 2005 Aug 4. Circ Res. 2005. PMID: 16081872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,484 results

Search Page